Leveraged and inverse exchange traded funds have been facing a lot of regulatory heat lately, but the products and the companies that provide them are expected to withstand the scrutiny.

The summer saw several companies – including UBS, Ameriprise, Edward Jones, Morgan Stanley, Wells Fargo Advisors and LPL Financial – impose restrictions on leveraged and inverse ETFs.